Form 4: Aura Biosciences Chief Medical Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Janet Jill Hopkins, Chief Medical Officer of Aura Biosciences, sold 2,534 shares of common stock on February 18, 2025, to cover tax withholding obligations related to vesting restricted stock units.
Summary
- On February 18, 2025, Janet Jill Hopkins, the Chief Medical Officer of Aura Biosciences, sold 2,534 shares of the company's common stock.
- The shares were sold at a price of $7.75 per share.
- This transaction was executed to cover tax withholding obligations associated with the vesting of restricted stock units.
- Following the sale, Hopkins directly owns 269,794 shares of Aura Biosciences.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (sale of shares to cover taxes) and doesn't contain any information that would significantly impact investor sentiment positively or negatively.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock units are a common practice among company executives and employees.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of stock sale transaction and signature date. |
Keywords
Aura Biosciences, AURA, Janet Jill Hopkins, Chief Medical Officer, stock sale, Form 4, tax withholding, restricted stock units, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.